|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
��ͷ״������,�� |
|
���ﲢ��֢,��Ⱦ�� |
|
��������,��ֱ |
| ��������������� | |
|
�ξ� |
|
������ |
|
���� |
| PubMed | |
|
Article by |
|
Article by |
|
Article by |
����������ͷ�������ĸ�Ⱦ״����ĸӤ�������о���չ
�ξ�, ������, ��С��
����ҽѧԺ߮�ɽҽԺƤ���Բ���, �ߺ�241001
Ů����ֳ������ͷ��������Ⱦ�÷�����������,��������Ĺ�ϵ���ܹ�ע������������������ͷ�������ĸ�Ⱦ״��������ͷ��������ĸӤ����;������������Ⱦ�ʼ���Ӱ�����ء��������ѡ���Ե���������ͷ������16/18���͵�����,���ܴ��ڹ���ĸӤ��������ͷ��������;��,��ĸѪ�еĿ�HPV����ɾ�̥�̽���������Ѫѭ�������ƹ��ڴ�����
[2] Czegledy J, Gergely L, Endrodi 1. Detection of human papillomavirus deoxyribonucleic acid by filter in situ hybridization during pregnancy.J Med Virol, 1989, 28:250-254.
[3] Fife KH, Katz BP, Roush J, et al. Cancer-associated human papillomavirus types are selectively increased in the cervix of women in the first trimester of pregnancy. Am J Obstet Gynecol, 1996, 174 (5):1487-1493.
[4] Szepietowska M, Slodzinski H, Polz-Dacewicz M, et al. Evaluation of frequency human papillomavinus infections during pregnancy. Ginekol Pol, 2002, 73:662-665.
[5] Armbruster-Moraes E, loshimoto LM, Leao E, et al. Prevalence of 'high risk' human papillomavirus in the lower genital tract of Brazilian gravidas. Int J Gynaecol Obstet, 2000, 69:223-227.
[6] Fife KH, Katz BP, Brizendine EJ, et al. Cervical human papillomavirus deoxyribonucleic acid persists throughout pregnancy and decreases in the postpartum period. Am J Obstet Gynecol, 1999,180:1110.
[7] Rando RF, Lindheim S, Hasty L, et al. Increased frequency of detection of human papillomavirus deoxyribonucleic acid in exfoliated cervical cells during pregnancy. Am J Obstet Gynecol, 1989, 161:50.
[8] Nobbenhuis MA, Helmerhorst TJ, van den Brule AJ, et al. High-risk human papillomavirus clearance in pregnant women:trends for lower clearance during pregnancy with a catch-up postpartum. Br J Cancer,2002, 87:75-80.
[9] de Roda Husman AM, Walboomers JM, Hopman E, et al. HPV prevalence in cytomorphologically normal cervical scrapes of pregnant women as determined by PCR:the age-related pattern. J Med Virol,1995, 46:97-102.
[10] Tenti P, Zappatore R, Migliora P,et al. Latent human papillomavirus infection in pregnant women at term:a case-control study. J Infect Dis, 1997, 176:277-280.
[11] Chan PK, Chang AR, Tam WH, et al. Prevalence and genotype distribution of cervical human papillomavirus infection:Comparison between pregnant women and non-pregnant controls. J Med Virol,2002, 67:583-588.
[12] Hagensee ME, Slavinsky J 3rd, Gaffga CM, et al. Seroprevalence of human papillomavirus type 16 in pregnant women. Obstet Gynecol,1999, 94:653-658.
[13] Mittal R, Tsutsumi K, Pater A, et al. Human papillomavirus type 16 expression in cervical keratinocytes:role of progesterone and glucocorticoid hormones. Obstet Gynecol, 1993, 81:5-12.
[14] Morales-Peza N, Auewarakul P, Juarez V,et al. In vivo tissue-specif-ic regulation of the human papillomavirus type 18 early promoter by estrogen, progesterone, and their antagonists. Virology, 2002, 294:135.
[15] Veress G, Csiky-Meszaros T, Konya J, et al. Follow-up of human papillomavirus (HPV) DNA and local anti-HPV antibodies in cytologically normal pregnant women. Med Microbiol Immunol (Berl),1996, 185:139-144.
[16] Sethi S, Muller M, Schneider A,et al. Serologic response to the E4,E6, and E7 proteins of human papillomavirus type 16 in pregnant women. Am J Obstet Gynecol, 1998, 178:360-364.
[17] Syrjanen S, Puranen M. Human papillomavirus infections in children:the potential role of maternal transmission. Crit Rev Oral Biol Med,2000,11:259-274.
[18] Puranen MH, Yliskoski MH, Saarikoski SV, et al. Exposure of an infant to cervical human papillomavirus infection of the mother is common. Am J Obstet Gynecol, 1997,176:1039-1045.
[19] Wang X, Zhu Q, Rao H. Maternal-fetal transmission of human papillomavirus. Chin Med J (Engl), 1998,111:726-727.
[20] Smith EM, Johnson SR, Cripe T,et al. Perinatal transmission and maternal risks of human papillomavirus infection. Cancer Detect Prev,1995, 19:196-205.
[21] Watts DH, Koutsky LA, Holmes KK, et al. Low risk of perinatal transmission of human papillomavirus:results from a prospective cohort study. Am J Obstet Gynecol, 1998, 178:365-373.
[22] Tenti P, Zappatore R, Migliora P, et al. Perinatal transmission of human papillomavirus from gravidas with latent infections. Obstet Gynecol, 1999, 93(4):475-479.
[23] Kawana K, Yasugi T, Yoshikawa H, et al. Evidence for the presence of neutralizing antibodies against human papillomavirus type 6 in infants born to mothers with condyloma acuminata. Am J Perinatol,2003, 20(1):11-16.
[24] Eppel W, Worda C, Frigo P,et al. Human papillomavirus in the cervix and placenta. Obstet Gynecol, 2000, 96 (3):337-341.